Research › Fact Sheets › LH

LABCORP HOLDINGS INC.

LISTEDNYSE

SYMBOLLH

SIC8071

STATE OF INC.–

FISCAL YEAR ENDSDecember 31

CIK920148

SERVICES-MEDICAL LABORATORIES · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)	Amount	%
Total debt	5,585	39.3
Stockholders' equity	8,620	60.7
Total capitalization	14,204	100.0

81,100,000 shares outstanding at 4 August 2026 (cover page of the 10-Q filed 5 August 2026).

LONG-TERM DEBT 12/31/25

($ millions)	Amount
Long-term debt, noncurrent	5,085
Current maturities	500

CAPITAL STOCK 12/31/25

Common shares authorized	265,000,000
Common shares issued	82,200,000
Outstanding at 8/4/26	81,100,000

DIVIDENDS DECLARED/PAID

Fiscal year	Per share $	Payout %
2025	2.88	27.5
2024	2.88	32.6
2023	2.88	60.4
2022	2.16	15.5
2021	–	–

HISTORY AND BUSINESS

HISTORY: State of incorporation not stated in SEC records. Formerly known as LABORATORY CORP OF AMERICA HOLDINGS (to 16 May 2024); NATIONAL HEALTH LABORATORIES HOLDINGS INC (to 13 February 1995).

BUSINESS: Classified by the SEC under Standard Industrial Classification 8071, Services-Medical Laboratories. Large accelerated filer. Principal executive office: 358 S Main St, Burlington, NC 27215. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)	12/31/25	12/31/24	12/31/23
Revenues	13,952	13,009	12,162
Cost of revenues	9,939	9,384	8,797
Gross profit	4,012	3,624	3,365
Selling, general and administrative	2,216	2,230	2,021
Depreciation and amortization	681	644	577
Operating income	1,385	1,087	726
Interest expense	224	208	200
Income before income taxes	729	630	504
Income taxes	230	212	188
Net income	876	746	418
Earned per share, diluted ($)	10.46	8.84	4.77
Dividends per share ($)	2.88	2.88	2.88

CONSOLIDATED BALANCE SHEET

($ millions)	12/31/25	12/31/24
Cash and equivalents	532	1,519
Receivables, net	2,104	1,944
Inventories	535	493
Total current assets	4,020	4,806
Property, plant and equipment, net	3,082	3,045
Goodwill	6,790	6,370
Total assets	18,393	18,379
Total current liabilities	2,824	3,330
Long-term debt	5,085	5,331
Total liabilities	9,756	10,312
Stockholders' equity	8,620	8,052
Total liabilities and equity	18,393	18,379

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year ended	Revenues	Oper. income	Net income	Net margin %	EPS diluted $	Div. per share $	Oper. cash flow	Capital expend.	Free cash flow	Total assets	Total liabilities	Total debt	Stockholders' equity	ROE %	Debt / equity
12/31/25	13,952	1,385	876	6.3	10.46	2.88	1,640	434	1,206	18,393	9,756	5,585	8,620	10.2	0.65
12/31/24	13,009	1,087	746	5.7	8.84	2.88	1,586	490	1,096	18,379	10,312	6,332	8,052	9.3	0.79
12/31/23	12,162	726	418	3.4	4.77	2.88	1,328	454	874	16,725	8,835	5,054	7,875	5.3	0.64
12/31/22	11,864	1,436	1,279	10.8	13.97	2.16	1,956	429	1,527	20,155	10,040	5,340	10,097	12.7	0.53
12/31/21	13,136	3,049	2,377	18.1	24.39	–	3,110	422	2,688	20,385	10,091	5,418	10,273	23.1	0.53
12/31/20	13,978	2,445	1,556	11.1	15.88	–	2,135	382	1,754	20,072	10,614	5,796	9,437	16.5	0.61
12/31/19	11,555	1,330	824	7.1	8.35	–	1,445	400	1,044	18,046	10,459	6,205	7,644	10.8	0.81
12/31/18	11,333	1,326	884	7.8	8.61	–	1,305	380	926	16,185	9,195	6,001	7,048	12.5	0.85
12/31/17	10,308	1,305	1,227	11.9	11.81	–	1,498	313	1,185	16,673	9,848	6,696	6,804	18.0	0.98
12/31/16	9,553	1,271	712	7.5	6.82	–	1,197	279	918	14,247	8,726	5,778	5,518	12.9	1.05

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

LABCORP HOLDINGS INC.
CIK 920148 · EIN 99-2588107

PRINCIPAL OFFICE:

358 S Main St, Burlington, NC 27215
Tel.: 3362291127

INCORPORATED:

–

INDUSTRY (SEC SIC CODE):

8071 · Services-Medical Laboratories

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 24 February 2026

FORMER NAMES:

LABORATORY CORP OF AMERICA HOLDINGS; NATIONAL HEALTH LABORATORIES HOLDINGS INC

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

9/30/26	8-K	period 9/30/26
9/22/26	8-K	period 9/22/26
9/10/26	8-K	period 9/10/26
8/28/26	8-K	period 8/28/26
8/17/26	8-K	period 8/17/26
8/14/26	8-K	period 8/11/26
8/5/26	10-Q	period 6/30/26
7/30/26	8-K	period 7/30/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/24/26) · 10-K FY2024 (filed 2/25/25) · 10-K FY2023 (filed 2/26/24) · 10-K FY2021 (filed 2/28/23) · 10-K FY2021 (filed 2/25/22) · 10-K FY2020 (filed 2/25/21) · 10-K FY2019 (filed 2/28/20) · 10-K FY2018 (filed 2/28/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.